From an Eli Lilly campus where pharmaceuticals are made to a new medical school and innovation district, the Charlotte region ...

The companies were the latest to agree to sell drugs to Medicaid and directly to consumers at discounted prices. President ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...

When President Donald Trump declared in May that he wanted drug companies to voluntarily cut their prices, few pharmaceutical ...

The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.

Friday’s announcement is the latest in a series of events in which Trump has boasted of securing cooperation from drug makers ...

The President said more deals would be announced next week, and suggested White House pressure will also come to bear on health insurers soon.

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies.

Next year is an election year and they’re notoriously volatile for markets. That means investors should be open to the ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S.

The perception of GLP-1s — and the people who use them — is getting better, but work still must be done to avoid stigma.